LHC Group (LHC Group) Cash, Cash Equivalents, Marketable Securities : $18 Mil (As of Dec. 2022)

View and export this data going back to 2005. Start your Free Trial

What is LHC Group Cash, Cash Equivalents, Marketable Securities?

LHC Group's quarterly cash, cash equivalents, marketable securities declined from Jun. 2022 ($27.40 Mil) to Sep. 2022 ($10.52 Mil) but then increased from Sep. 2022 ($10.52 Mil) to Dec. 2022 ($17.91 Mil).

LHC Group's annual cash, cash equivalents, marketable securities declined from Dec. 2020 ($286.57 Mil) to Dec. 2021 ($9.81 Mil) but then increased from Dec. 2021 ($9.81 Mil) to Dec. 2022 ($17.91 Mil).

LHC Group Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for LHC Group's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LHC Group Cash, Cash Equivalents, Marketable Securities Chart

LHC Group Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash, Cash Equivalents, Marketable Securities

Get a 7-Day Free Trial

49.36

31.67

286.57

9.81

17.91

LHC Group Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial															9.81	7.68	27.40	10.52	17.91

LHC Group Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

LHC Group (NAS:LHCG) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

LHC Group Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of LHC Group's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

LHC Group (LHC Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » LHC Group Inc (NAS:LHCG) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

901 Hugh Wallis Road South, Lafayette, LA, USA, 70508

Website

https://www.lhcgroup.com

LHC Group Inc provides post-acute health care services to patients through its home nursing agencies, community-based services agencies, hospice agencies, and long-term acute care hospitals. The company's home health service locations offer a wide range of services, including skilled nursing, medically-oriented social services and physical, occupational, and speech therapy. Its hospices provide end-of-life care to patients with terminal illnesses through interdisciplinary teams of physicians, nurses, home health aides, counselors, and volunteers. Its other service segments are Home and community based, Facility-based, Hospice and Healthcare Innovations. The company derives most of its revenues from the Home health services.

Executives

Nicholas Iii Gachassin	officer: EVP, General Counsel	901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA 70508
Dale Mackel	other: CFO	901 HUGH WALLIS ROAD S, LAFAYETTE LA 70508-2511
Reed W Earl Iii	director	9510 OMSBY SLATION ROAD, STE 300, LOIISVILLE KY 40223
Kimberly S Seymour	other: SVP, Chief Accounting Officer	901 HUGH WALLIS ROAD S, LAFAYETTE LA 70508
Tricia Nguyen	other: EVP, Chief Medical Officer	1801 KIRA COURT, ARLINGTON TX 76006
Mcquiddy Collin	other: SVP, Chief Accounting Officer	901 HUGH WALLIS ROAD S, LAFAYETTE LA 70508
Donald Dwayne Stelly	officer: Senior Vice President	420 WEST PINHOOK ROAD, SUITE A, LAFAYETTE LA 70503
John L Indest	director, officer: COO of Home, Senior V.P.	420 WEST PINHOOK ROAD, SUITE A, LAFAYETTE LA 70503
Ronald T Nixon	director	1375 ENCLAVE PKWY, HOUSTON TX 77077
Keith G Myers	director, 10 percent owner, officer: CEO and President	901 HUGH WALLIS RD S, LAFAYETTE LA 70508
Joshua L. Proffitt	officer: Executive Vice President	901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA 70508
Teri G. Fontenot	director	18933 EAST PINNACLE CIRCLE, BATON ROUGE LA 70634
Tyree G Wilburn	director
Jeff Reibel	officer: See Remarks	9510 ORMSBY STATION ROAD, SUITE 300, LOUISVILLE KY 40223
Bruce D Greenstein	officer: Chief Innovation Officer	901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA 70508